Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $4.08 in the prior trading day, Humacyte Inc (NASDAQ: HUMA) closed at $4.10, up 0.49%. In other words, the price has increased by $0.49 from its previous closing price. On the day, 1.63 million shares were traded. HUMA stock price reached its highest trading level at $4.22 during the session, while it also had its lowest trading level at $4.0127.
Ratios:
Our goal is to gain a better understanding of HUMA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 11, 2023, initiated with a Buy rating and assigned the stock a target price of $6.
On August 14, 2023, Piper Sandler Upgraded its rating to Neutral which previously was Underweight and also upped its target price recommendation from $2.75 to $3.50.
On June 22, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $6.Cantor Fitzgerald initiated its Overweight rating on June 22, 2023, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’24 when Constantino Michael T. bought 4,600 shares for $4.39 per share. The transaction valued at 20,181 led to the insider holds 16,950 shares of the business.
Niklason Laura E bought 1,797 shares of HUMA for $7,979 on Nov 19 ’24. The President, CEO and Director now owns 243,851 shares after completing the transaction at $4.44 per share. On Nov 19 ’24, another insider, Dougan Brady W, who serves as the Director of the company, bought 1,797 shares for $4.44 each. As a result, the insider paid 7,979 and bolstered with 243,851 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUMA now has a Market Capitalization of 527538784 and an Enterprise Value of 512970944.
Stock Price History:
Over the past 52 weeks, HUMA has reached a high of $9.97, while it has fallen to a 52-week low of $2.48. The 50-Day Moving Average of the stock is -18.10%, while the 200-Day Moving Average is calculated to be -24.27%.
Shares Statistics:
The stock has traded on average 3.03M shares per day over the past 3-months and 2438770 shares per day over the last 10 days, according to various share statistics. A total of 119.84M shares are outstanding, with a floating share count of 104.37M. Insiders hold about 18.88% of the company’s shares, while institutions hold 27.90% stake in the company. Shares short for HUMA as of 1732838400 were 20333918 with a Short Ratio of 6.71, compared to 1730332800 on 17250350. Therefore, it implies a Short% of Shares Outstanding of 20333918 and a Short% of Float of 20.36.